ATPS-05 CHARACTERIZATION OF THE ACTIVITY OF AT13387, A NOVEL SECOND GENERATION HSP90 INHIBITOR AGAINST GLIOMAS

Eitemau Tebyg

• ANGI-06 PAK4 GOVERNS RADIATION-INDUCED ENDOTHELIAL Gro-1α-CXCR2 SIGNALING AND ANGIOGENESIS IN GLIOMA
  gan: Kesanakurti, Divya, et al.
  Cyhoeddwyd: (2015)
• The succinct synthesis of AT13387, a clinically relevant Hsp90 inhibitor
  gan: Kaur, Jatinder, et al.
  Cyhoeddwyd: (2019)
• Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
  gan: Canella, Alessandro, et al.
  Cyhoeddwyd: (2017)
• ATPS-96 HISTONE DEACETYLASE INHIBITORS REPRESS HYPOXIA SIGNALING THROUGH AFFECTING HSP90
  gan: Yang, Chunzhang, et al.
  Cyhoeddwyd: (2015)
• EXTH-83. TARGETING DNA REPAIR AND SURVIVAL PATHWAYS THROUGH HEAT SHOCK PROTEIN INHIBITION USING AT13387 TO SENSITIZE GLIOMA TO CHEMORADIATION THERAPY
  gan: Wu, Jasmine P J, et al.
  Cyhoeddwyd: (2017)